Gastric Cancer Highlights Positive readout shared in February 2023 ESMO plenary showed significant improvement in mPFS and mOS in...

RCC Highlights Negative results from the Phase III IMmotion010, CheckMate-914 Part A, and PROSPER trials call into question the benefit...

Highlights Long-term follow-up analyses from Phase III SOLO-1 (olaparib maintenance treatment in 1L BRCAm ovarian cancer) and Phase III...

Highlights Results from monarchE (abemaciclib + ET) confirm the benefit of abemaciclib in in high risk, HR+ BC Although FDA ODAC voted...